Reduction of natural radioactivity in groundwater with different salinity through adsorption of uranium and radium in filter materials.

In many small communities in the Mediterranean area, groundwater is usually the only water body available. Depending mainly on the surrounding geology, their concentration of naturally occurring radionuclides may pose a radiological hazard. Removal of uranium and radium from drinking water is the best way to avoid it, i.e., reverse osmosis (RO), but consuming a lot of energy. Thus, two modified drinking water treatment plants (DWTPs) using zeolites coated with manganese dioxide as adsorbent material were analyzed as an alternative to RO. Groundwater salinity can negatively affect this process. Radium removal decreased as water salinity increased; but it had a major impact on uranium, rendering the adsorption effectless in one DWTP. Waste management and how to avoid it from becoming radioactive are of major concern. Radium and uranium were associated to the reducible fraction in the filter material and also to the carbonate fraction in the case of uranium. Regeneration of the filter material using KCl solutions was able to remove 81% and 63% of uranium and radium, respectively.

Introduction to the EQIPD quality system.

While high risk of failure is an inherent part of developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. Supported through the European Union's Innovative Medicines Initiative, the EQIPD consortium has developed a novel preclinical research quality system that can be applied in both public and private sectors and is free for anyone to use. The EQIPD Quality System was designed to be suited to boost innovation by ensuring the generation of robust and reliable preclinical data while being lean, effective and not becoming a burden that could negatively impact the freedom to explore scientific questions. EQIPD defines research quality as the extent to which research data are fit for their intended use. Fitness, in this context, is defined by the stakeholders, who are the scientists directly involved in the research, but also their funders, sponsors, publishers, research tool manufacturers, and collaboration partners such as peers in a multi-site research project. The essence of the EQIPD Quality System is the set of 18 core requirements that can be addressed flexibly, according to user-specific needs and following a user-defined trajectory. The EQIPD Quality System proposes guidance on expectations for quality-related measures, defines criteria for adequate processes (i.e. performance standards) and provides examples of how such measures can be developed and implemented. However, it does not prescribe any pre-determined solutions. EQIPD has also developed tools (for optional use) to support users in implementing the system and assessment services for those research units that successfully implement the quality system and seek formal accreditation. Building upon the feedback from users and continuous improvement, a sustainable EQIPD Quality System will ultimately serve the entire community of scientists conducting non-regulated preclinical research, by helping them generate reliable data that are fit for their intended use.